CNPOF - Canopy Rivers Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
2.3000
-0.0197 (-0.85%)
At close: 3:57PM EDT
Stock chart is not supported by your current browser
Previous Close2.3197
Open2.1500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.1500 - 2.3400
52 Week Range1.7500 - 7.3016
Volume101,482
Avg. Volume108,088
Market Cap128.729M
Beta (3Y Monthly)N/A
PE Ratio (TTM)8.85
EPS (TTM)0.2600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada
    CNW Group2 hours ago

    Canopy Rivers' Flagship PharmHouse JV Licensed By Health Canada

    TORONTO , July 22, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to announce that its 49%-owned joint venture, PharmHouse Inc.  ("PharmHouse"), has received a cultivation licence from Health Canada. PharmHouse will be immediately commencing operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products to the Canopy Rivers ecosystem of partners, both domestically and internationally. "This is a significant corporate milestone for Canopy Rivers.

  • Benzinga6 days ago

    Canopy Rivers Reports Q4 Earnings

    A venture capital investment company that seeks opportunities in the cannabis industry, Canopy Rivers (TSXV: RIV) (OTC: CNPOF ) released its financial report for the fourth quarter and fiscal year on Tuesday. ...

  • PR Newswire6 days ago

    Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financial Highlights and Provides Corporate Update

    TORONTO, July 16, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (RIV.V) (CNPOF) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.

  • Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta
    CNW Group13 days ago

    Canopy Rivers portfolio company YSS receives five new cannabis retail licences in Alberta

    TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company, YSS Corp. ("YSS") (TSXV:YSS) (WKN:A2PMAX), on receiving five cannabis retail licences from the Alberta Gaming, Liquor and Cannabis Commission ("AGLC"). Canopy Rivers currently holds approximately 8% of the issued and outstanding common shares in the capital of YSS on a fully-diluted basis.

  • Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada
    CNW Group14 days ago

    Canopy Rivers Portfolio Company Receives Key Licence Amendment from Health Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (JWCA.V) (JWCAF), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario .

  • Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada
    CNW Group14 days ago

    Canopy Rivers Portfolio Company Terrascend Receives Cannabis Oil Sales Licence in Canada

    TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF) on its announcement today that it has received an amendment to its licence from Health Canada allowing for the sale of cannabis oils from its facility in Mississauga, Ontario . This news comes two months following TerrAscend's announcement that it had been issued a Good Manufacturing Practice (GMP) certificate in accordance with the rules governing medical products in the European Union, in conjunction with establishing a sales and distribution agreement with iuvo Therapeutics GmbH, a German pharmaceutical wholesaler. "With another key milestone achieved by TerrAscend in a matter of a few short months, the company continues to demonstrate its ambition to become a global provider of pharmaceutical-grade cannabis products," said Narbe Alexandrian, President and CEO of Canopy Rivers.

  • CNW Group19 days ago

    Canopy Rivers Announces Change to Board of Directors

    Canopy Rivers Announces Change to Board of Directors

  • PR Newswirelast month

    Canopy Rivers to Report Fourth Quarter and Fiscal Year 2019 Financial Results

    TORONTO, June 19, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company") (RIV.V) (CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019.

  • PR Newswirelast month

    Canopy Rivers Makes US$10 Million Investment in Plant Genetics Innovator ZeaKal

    TORONTO and SAN DIEGO, June 19, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (RIV.V) (CNPOF) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.

  • CNW Grouplast month

    Canopy Rivers announces grant of options

    Canopy Rivers announces grant of options

  • PR Newswire2 months ago

    Canopy Rivers Hosts Analyst and Investor Day on May 28 - Live Webcast Available

    TORONTO, May 28, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V), (CNPOF) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28. The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition.  This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • PR Newswire2 months ago

    Canopy Growth subsidiary and Canopy Rivers portfolio company Vert Mirabel now fully licensed by Health Canada

    MIRABEL, QC, May 28, 2019 /PRNewswire/ - Les Serres Vert Cannabis Inc. ("Vert Mirabel"), a subsidiary of Canopy Growth Corporation (WEED.TO) (CGC) ("Canopy Growth") and a portfolio company of Canopy Rivers Inc. (RIV.V) (CNPOF) ("Canopy Rivers") has received its final cultivation licence from Health Canada. All 700,000 sq. ft. of operating space at Vert Mirabel is now licensed for cannabis production. Vert Mirabel was established in December 2017 between Canopy Growth, Canopy Rivers, and Les Serres Stéphane Bertrand ("Bertrand"). "We are thrilled that the operational infrastructure at Vert Mirabel is now fully online with over 500,000 sq. ft. already in production," said Olivier Dufourmantelle, Chief Operating Officer, Canopy Rivers.

  • PR Newswire2 months ago

    Canopy Rivers Hosts analyst and Investor Day

    TORONTO, May 23, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) today announced that it will host an analyst and investor day on Tuesday, May 28 from 1:00 p.m. to 5:00 p.m. ET. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition. This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.

  • Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence
    CNW Group2 months ago

    Canopy Rivers Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

    TORONTO , May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada .